ASX Limited

Price A$51.28 · Mkt cap A$9.94b · 194.1m shares · as of 25 June 2026 · FY ends 30 June · AUD · prepared through the Franchise Blueprint (v3)

Accumulate below A$42 (deep value < A$38). An elite, statutory clearing-and-settlement monopoly whose compounding engine is currently throttled by a multi-year cost/capex step-up — a great franchise at the wrong price, not yet a margin-of-safety entry.

Executive Summary

ASX is the vertically-integrated operator of Australia's equity, derivatives and fixed-income markets and — critically — the statutory monopoly in cash-equity clearing and settlement, riding a legislated superannuation tailwind (the pool growing from ~A$4.1tn toward ~A$8tn by 2035). The franchise clears the Quality Gate and the hard Truth Tests, and its earnings are highly predictable a decade out. But this is not the elite capital-light-compounder lane: consensus has EPS roughly flat-to-declining for three years (−0.4%/yr) while a twice-upgraded cost programme (FY26 expense growth 20–23%, FY27 capex A$180–200m) and a forced A$150m capital build compress returns; forecast ROE slips to ~11.9%, barely above the required return. At A$51.28 the reverse-DCF shows the market pricing only ~3% perpetual growth — not heroic, but the resulting base-case owner's return is only ~7–8% p.a., well below the 12–15% hurdle, and the stock trades ~19% above a conservative Working IV of ~A$43. The franchise is too good to abandon and too dear to add to here. Disposition: hold the existing 200-share Tranche 1; keep Tranches 2–3 dry; accumulate the genuine margin of safety in the low-A$40s and below.

Decision Matrix — buy only if all hold

Governing principle: approximately right beats precisely wrong. The two variables that decide a 5–10 year outcome are moat width and earnings predictability — they determine whether the compounding machine runs. Here the moat is wide and the franchise predictable, but the machine is throttled; valuation exists to give an honest range and to stop us overpaying for a compounding rate the business is not currently delivering.

1.0 Quality Gate — the six criteria

1 · Durable moat. PASS A single, nameable, near-unassailable source: the statutory/regulatory monopoly in cash-equity clearing and settlement (CHESS), reinforced by the liquidity/efficient-scale advantage of a vertically-integrated venue and a disproportionately large listings franchise tied to Australia's resources sector. Operating ROIC sits far above WACC (the equity base is dominated by regulatory/CCP capital, which depresses reported ROE to ~13% but flatters operating returns); gross margin ~93% and EBITDA margin ~61–63% have been stable through cycles.

2 · FCF & buybacks. MARGINAL Cash backs earnings well (FCF ~A$540m vs earnings ~A$523m; FCF/NI >100% on a normalised basis). But there are no buybacks, share count creeps slightly, and ASX is now forced to retain capital (the A$150m above-NTA build to 30 June 2027). Capital return is constrained, not optimised — Marginal.

3 · Recurring revenue. PASS Listings, clearing, settlement, technical and data revenue are recurring/transactional; the book grew through both the GFC and COVID (FY20 EPS rose); no customer concentration >~10%. Trading volumes are mildly cyclical but the regulated rails are sticky.

4 · Pricing power. MARGINAL Structurally strong (a monopoly sets the toll), but regulator-capped — fee changes face ACCC/ASIC scrutiny, and the current intensive-supervision environment makes assertive pricing harder near-term. Real, but constrained.

5 · Compounding. MARGINAL This is the binding weakness. The secular tailwind (super pool roughly doubling by 2035) is real, but ROE (~13%, forecast ~11.9%) is only modestly above the required return and the per-share compounding engine is currently stalled — EPS flat-to-down for three years while the cost/capex step-up runs. A long runway saves it from Fail; the machine is not running today.

6 · Network effect. MARGINAL Genuine liquidity network effect in trading/clearing (liquidity begets liquidity, and rising volume on rival venues still clears through ASX), but the listings edge faces credible competition (TMX's acquisition of Cboe Australia targets new primary listings, especially mining). More "efficient scale + regulatory moat" than a classic multi-sided network.

2.0 Truth Tests — people, fortress, numbers & predictability

2.1 · The Jockey. MARGINAL Management is mid-transition — Helen Lofthouse departed (May 2026), Darren Yip is interim, and Anthony Attia (Euronext post-trade and multi-venue pedigree — directly relevant) becomes MD & CEO on 1 September 2026; board average tenure is just ~1.9 years. The ASIC inquiry found governance and cultural shortcomings (the basis for the A$150m charge and the Accelerate reset), and the abandoned blockchain-CHESS write-down (~A$250m, 2022) is a real historical misallocation. None of this is egregious or fraudulent — the company is settling, resetting governance, and importing relevant expertise — so it clears the hard gate, but the 10-year record is Marginal. Hard gate: PASS (not egregious).

2.2 · The Fortress. PASS Corporate balance sheet is robust: net-cash at the corporate level (total debt ~A$275m against ~A$5.1b cash, much of it CCP-related), debt/equity ~7%, and a regulatory capital buffer that is growing by mandate. It would survive two years of zero growth and a frozen credit market without a dilutive raise. Hard gate: PASS.

2.3 · Earnings quality. PASS SWS flags high-quality earnings; cash conversion is strong (FCF ≥ net income on a normalised basis); accruals are clean; the "underlying vs statutory" bridge (Sympli loss, prior write-downs) is disclosed and one-off. No related-party or recognition red flags. Hard gate: PASS.

2.4 · Moat trajectory. STABLE (narrowing edge) The core clearing/settlement rail is stable-to-strengthening (CHESS Release 1 went live April 2026 — the key binary risk resolved positively). The listings perimeter is narrowing under Cboe/TMX competition, and S&P cut the credit rating from AA− to A+. Net: a wide moat, stable at the core, with a watch on the edge.

2.5 · Normalized earnings. Mid-cycle owner earnings ~A$510–525m (underlying NPAT A$510m FY25; LTM ~A$523m), EBITDA margin normalised to ~61% (from ~63%, reflecting the step-up), normalised FCF ~A$520m. Earnings are flat at a structural high, not cyclically depressed — the classic EPV inversion. Removed: Sympli divestment loss and prior CHESS write-downs.

2.6 · Predictability Test — the gate to valuation

PREDICTABILITY: HIGH (franchise)

Sub-tests average ~10/12 → High: the franchise is forecastable a decade out. Caveat carried into valuation: high predictability of the monopoly does not pin the near-term earnings level, which the cost/capex programme makes the live uncertainty. This is why the IV band is kept wide and the entry discipline is enforced rather than relaxed.

3.0Valuation — a range, never a point

3.0 · The 5-year cash-flow forecast

Band kept wide to reflect that the uncertainty is the earnings level, not the franchise; projected off normalised ~61% margins.

3.1 · The nine-method valuation stack

Working IV ≈ A$43 (centre of the legitimate cluster — the growth-crediting DCF/multiple ~A$46–48 tempered toward the no-growth floors EPV A$30 / Montgomery A$24; SOTP and Street target shown but not counted) · IV range ~A$30–50 · downside floor (EPV) ~A$30, hard accounting floor A$6. Reverse-DCF check: price implies ~3% growth — no veto, but "not heroic" is not "cheap": at a ~5.3% earnings yield, ~3% growth yields only a ~8% return.

4.0 Price, Catalysts, Risk & Expected Return

Margin of safety: at A$51.28 the stock trades ~19% above the conservative Working IV (~A$43) — MoS is negative. Forward frame considered and rejected as a rescue: the elite-compounder override (assess MoS one-year-forward as IV compounds at its own rate) does not apply, because ASX's IV is compounding at only ~3% — one year forward it is ~A$44, still well below price. Relaxing the static gate here would be the inverse category error: manufacturing a false BUY on a fairly-valued, low-growth name. Return engine: the bet would rely on a future earnings re-acceleration (cost step-up rolling off + super tailwind), not on compounding available today; the base case holds the multiple flat (no named de-rate catalyst — and no re-rate is assumed either).

4.2 · Scenario asymmetry

Asymmetry (base 5-yr value-gain : severe-bear loss) = ~0.6:1 at A$51 — inverted (more downside than upside); require ≥ 3:1. Computed on the multi-year owner-value frame per the High-predictability rule. The ratio turns favourable (≈3:1) only around A$36–38. Size to the bear-case loss — which at today's price is the dominant outcome to underwrite.

4.4 · Catalyst & Risk Ledger

4.5 · Expected 5–10yr owner's return (headline)

Hurdle: base-case IRR ≥ ~12–15% p.a. Base ~7–8% fails it; even the bull only grazes the bottom. The franchise is elite; the price does not deliver a compounder's return. This headline metric, not the IV point estimate, is what drives the WATCH.

5.0 Portfolio Fit & Sizing

Squarely inside the circle of competence (a deeply-researched, multi-session holding). As an Australian tax resident the fully-franked dividend stream is genuinely attractive on an after-tax/grossed-up basis (~6.3% grossed-up), which supports holding the existing 200 shares (Tranche 1, ~A$50.77 cost) as a bond-annuity sleeve. But fresh capital at A$51 does not clear the after-tax total-return hurdle and would not beat a disciplined cash position waiting for the genuine-MoS zone. Sizing = conviction × MoS, capped by the bear-case loss: with MoS negative, the disciplined add size at A$51 is zero. Reserve Tranche 2 (A$46.50, fair-value accumulation, optional) and Tranche 3 (A$42, the first genuine-MoS add), with conviction building below A$38.

6.0 Monitoring & Sell Triggers

Watch quarterly: (1) a third cost/capex upgrade or FY27 guidance worse than the 13–16% ex-D&A path → the margin-compression risk turns structural (downgrade); (2) any CHESS R2 milestone slip → renewed cost/regulatory risk; (3) listings-share erosion to Cboe/TMX beyond mining; (4) the one overriding structural sell trigger — any credible legislative move toward forced competition in clearing & settlement → exit regardless of price; (5) earnings-quality or governance regression under new management. Conversely, a clean FY26 result (13 Aug) + firm cost guidance + Attia delivering a credible capital-allocation reset would justify upgrading toward BUY into the high-A$40s. Overshoot trim level: well above ~A$60 on an unchanged earnings trajectory.

6.5 Revealed Smart-Money Cross-Check

(MANDATORY PRE-VERDICT GATE)

The style-matched archetype for a financial-infrastructure monopoly is TCI / Chris Hohn (historic LSEG involvement; long owner of monopoly franchises). The read:

Corroborates the verdict. Smart money likes exchange monopolies (quality confirmed) but is price- and growth-disciplined; the WATCH ("great business, wrong price") is consistent with that behaviour, not contradicted by it. No bug-report re-examination of WACC/MoS/growth assumptions is triggered — the inputs and the disposition agree.

7.0 Verdict

WATCH — hold the existing 200 shares; accumulate below A$42 (deep value < A$38). The binding constraint is price, not durability: ASX is a wide-moat, highly-predictable statutory monopoly (Score 16/22, B+) whose compounding engine is throttled by a real, twice-confirmed cost/capex step-up, leaving the base-case owner's return (~7–8%) below the hurdle and the stock ~19% above conservative IV with inverted asymmetry. The specific, observable signal that would confirm the thesis and justify an upgrade is a clean FY26 result (13 Aug 2026) with firm cost/capex guidance that caps the step-up — the moment the earnings trajectory re-inflects, the compounding machine restarts and the franchise re-rates.

Contrarian falsification: "The market believes the cost/capex step-up permanently impairs ASX's earnings power; I am betting it is a temporary investment phase that rolls off post-FY28 and the monopoly's compounding resumes; I am wrong if FY27 brings a third cost upgrade or the step-up proves structural — in which case the genuine-value zone is lower still, not here."

Not investment advice.

Built from public filings and third-party data (ASX FY25 & 1H26 results, the 26 May 2026 guidance update, the uploaded Simply Wall St report, Morningstar, stockanalysis.com and press), point-in-time as of 25 June 2026. Intrinsic-value views are model outputs; estimated/normalised figures are labelled. The Franchise Score, gates and verdict are a structured synthesis, not advice from a licensed adviser. Verify against primary filings before acting.